Corrigendum to “Illudin S inhibits p53-Mdm2 interaction for anticancer efficacy in colorectal cancer” [Biomed. Pharmacother. 182 (2025) 117795](S0753332224016822)(10.1016/j.biopha.2024.117795)

Yoonsuk Lee, Yun Young Lee, Jinyoung Park, Anna Maksakova, Donghyuk Seo, Jisun Kim, Ji Eun Yeom, Yewon Kim, Cheol Hwi Kim, Rhim Ryoo, Se Na Kim, Juwon Park, Wooram Park, Tae Hyung Kim, Young Bin Choy, Chun Gwon Park, Ki Hyun Kim, Wonhwa Lee

Research output: Contribution to journalComment/debate

Abstract

The authors regret <insert corrigendum text>. * Correspondence to: Department of Biomedical Engineering, Institute for Cross-disciplinary Studies, Sungkyunkwan University, Suwon 16419, Republic of Korea. * * Correspondence to: School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea * ** Correspondence to: Department of Chemistry, Sungkyunkwan University, Suwon 16419, Republic of Korea.

Original languageEnglish
Article number117810
JournalBiomedicine and Pharmacotherapy
Volume183
DOIs
StatePublished - Feb 2025

Fingerprint

Dive into the research topics of 'Corrigendum to “Illudin S inhibits p53-Mdm2 interaction for anticancer efficacy in colorectal cancer” [Biomed. Pharmacother. 182 (2025) 117795](S0753332224016822)(10.1016/j.biopha.2024.117795)'. Together they form a unique fingerprint.

Cite this